Top

Published in:

01-07-2010 | Review

Artificial valves “up to date” in Japan

Authors: Shigehiko Tokunaga, Ryuji Tominaga

Published in: Journal of Artificial Organs | Issue 2/2010

Abstract

We have many choices when selecting artificial valves for valve replacement surgery. It is necessary to know the characteristics of the various prosthetic valves to make an appropriate decision for each valvular heart disease patient. In this review paper, we describe the features and benefits of the artificial valves available in Japan. Standard and new generation bioprostheses and mechanical prostheses are reviewed. The new technology of the catheter-delivery heart valve is also mentioned in this paper.

Production of the St. Jude Medical, Inc., Toronto SVP Stentless Porcine Bioprosthesis (St. Jude Medical, Inc., St. Paul, MN) was suspended in 2009. A clinical trial of this valve was done in Japan, but the valve was not commercially available.

Sales of the Edwards-MIRA bileaflet valve (Edwards Lifesciences, Irvine, CA) was suspended in December 2007 in Japan. Similarly, sales of the Omnicarbon monoleaflet valve (CV Medical Inc., Inver Grove Heights, MN), Medtronic Advantage bileaflet valve (Medtronic, Inc., Minneapolis, MN) and Medtronic-Hall mechanical valve (Medtronic, Inc., Minneapolis, MN) were also suspended in March 2006, June 2007 and June 2009, respectively, in Japan.

Banbury MK, Cosgrove DM, White JA, Blackstone EH, Frater RWM, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001;72:753–7.CrossRefPubMed

Marchand MA, Aupart MR, Norton R, Goldsmith IRA, Pelletier LC, Pellerin M, Dubiel T, Daenen WJ, Herijgers P, Casselman FP, Holden MP, David TE. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001;71:S236–9.CrossRefPubMed

Bortolotti U, Milano A, Mossuto E, Mazzaro E, Thien G, Casarotto D. Porcine valve durability: a comparison between Hancock standard and Hancock II bioprostheses. Ann Thorac Surg. 1995;60:S216–20.CrossRefPubMed

Valfrè C, Rizzoli G, Zussa C, Ius P, Polesel E, Mirone S, Bottio T, Gerosa G. Clinical results of Hancock II versus Hancock Standard at long-term follow-up. J Thorac Cardiovasc Surg. 2006;132:595–601.CrossRefPubMed

Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15:49–56.PubMed

Totaro P, Degno N, Zaidi A, Youhana A, Argano V. Carpentier-Edwards PERIMOUNT Magna bioprosthesis: a stented valve with stentless performance? J Thorac Cardiovasc Surg. 2005;130:1668–74.CrossRefPubMed

Riess F-C, Bader R, Cramer E, Hansen L, Kleijnen B, Wahl G, Wallrath J, Winkel S, Bleese N. Hemodynamic performance of the medtronic mosaic porcine bioprosthesis up to ten years. Ann Thorac Surg. 2007;83:1310–8.CrossRefPubMed

Cohen G, Christakis GT, Joyner CD, Morgan CD, Tamariz M, Hanayama N, Mallidi H, Szalai JP, Katic M, Rao V, Fremes SE, Goldman BS. Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg. 2002;73:767–78.CrossRefPubMed

Borger MA, Prasongsukarn K, Armstrong S, Feindel CM, David TE. Stentless aortic valve reoperations: a surgical challenge. Ann Thorac Surg. 2007;84:737–44.CrossRefPubMed

10.

Lopez S, Mathieu P, Pibarot P, Mohammadi S, Dagenais F, Voisine P, Dumesnil J, Doyle D. Does the use of stentless aortic valves in a subcoronary position prevent patient–prosthesis–mismatch for small aortic annulus? J Card Surg. 2008;23:331–5.CrossRefPubMed

11.

Bach DS, Kon ND, Dumesnil JG, Sintek CF, Doty DB. Ten-year outcome after aortic valve replacement with the Freestyle stentless bioprosthesis. Ann Thorac Surg. 2005;80:480–7.CrossRefPubMed

12.

Jin XY, Ratnatunga C, Pillai R. Performance of Edwards prima stentless aortic valve over eight years. Semin Thorac Cardiovasc Surg. 2001;13(4 Suppl 1):163–7.PubMed

13.

Willems TP, Takkenberg JJM, Steyerberg EW, Kleyburg-Linkers VE, Roelandt J, Bos E, van Herwerden LA. Human tissue valves in aortic position: determinants of reoperation and valve regurgitation. Circulation. 2001;103:1515–21.PubMed

14.

Emery RW, Krogh CC, Arom KV, Emery AM, Benyo-Albrecht K, Joyce LD, Nicoloff DM. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg. 2005;79:776–82.CrossRefPubMed

15.

Tominaga R, Kurisu K, Ochiai Y, Tomita Y, Masuda M, Morita S, Yasui H. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg. 2005;68:784–9.CrossRef

16.

Aagaard J, Tingleff J. Fifteen years’ clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis. 2005;14:82–8.PubMed

17.

Takaseya T, Kawara T, Tokunaga S, Kohno M, Oishi Y, Morita S. Aortic valve replacement with 17-mm St. Jude Medical prostheses for a small aortic root in elderly patients. Ann Thorac Surg. 2007;83:2050–3.CrossRefPubMed

18.

Bach DS, Sakwa MP, Goldbach M, Petracek MR, Emery RW, Mohr FW. Hemodynamics and early clinical performance of the St. Jude Medical Regent mechanical aortic valve. Ann Thorac Surg. 2002;74:2003–9.CrossRefPubMed

19.

Williams MA, van Riet S. The On-X heart valve: mid-term results in a poorly anticoagulated population. J Heart Valve Dis. 2006;15:80–6.PubMed

20.

Sezai A, Shiono M, Orime Y, Hata H, Yagi S, Negishi N, Sezai Y. Evaluation of valve sound and its effects on ATS prosthetic valves in patients’ quality of life. Ann Thorac Surg. 2000;69:507–12.CrossRefPubMed

21.

Van Nooten GJ, Van Belleghem Y, Caes F, François K, Van Overbeke H, Bové T, Taeymans Y. Lower-intensity anticoagulation for mechanical heart valves: a new concept with the ATS bileaflet aortic valve. J Heart Valve Dis. 2003;12:495–502.PubMed

22.

Stefanidis C, Nana AM, Cannière DD, Antoine M, Jansens J-L, Huynh C-H, Le Clerc J-L. 10-year experience with the ATS mechanical valve in the mitral position. Ann Thorac Surg. 2005;79:1934–8.CrossRefPubMed

23.

Bottio T, Caprili L, Casarotto D, Gerosa G. Small aortic annulus: The hydrodynamic performances of five commercially available bileaflet mechanical valves. J Thorac Cardiovasc Surg. 2004;128:457–62.CrossRefPubMed

24.

Ukpabi P, Marois Y, King M, Deng X, Martin L, Laroche G, Douville Y, Guidoin R. The Gelweave polyester arterial prosthesis. Can J Surg. 1995;38:322–31.PubMed

25.

Rastan AJ, Walther T, Daehnert I, Hambsch J, Mohr FW, Janousek J, Kostelka M. Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome. Ann Thorac Surg. 2006;82:1308–15.CrossRefPubMed

26.

Miyazaki T, Yamagishi M, Nakashima A, Fukae K, Nakano T, Yaku H, Kado H. Expanded polytetrafluoroethylene valved conduit and patch with bulging sinuses in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg. 2007;134:327–32.CrossRefPubMed

27.

Varadarajan P, Kapoor N, Bansal RC, Pai RG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged ≥80 years. Eur J Cardiovasc Surg. 2006;30:722–7.CrossRef

28.

Serruys PW. Keynote lecture; Transcatheter aortic valve implantation. Barcelona: EuroPCR2008; 2008.

29.

Al-Attar N, Himbert D, Descoutures F, Iung B, Raffoul R, Messika-Zeitoun D, Brochet E, Francis F, Ibrahim H, Vahanian A, Nataf P. Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg. 2009;87:1757–63.CrossRefPubMed

30.

Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A. Expanding the eligibility for transcatheter aortic valve implantation: the trans-subclavian retrograde approach using the III generation CoreValve Revalving System. JACC Cardiovasc Interv. 2009;2:828–33.CrossRefPubMed

31.

De Robertis F, Asgar A, Davies S, Delahunty N, Kelleher A, Trimlett R, Mullen M, Moat N. The left axillary artery: a new approach for transcatheter aortic valve implantation. Eur J Card Thorac Surg. 2009;36:807–12.CrossRef

32.

Cheung A, Webb JG, Wong DR, Ye J, Masson J-B, Carere RG, Lichtenstein SV. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87:e18–20.CrossRefPubMed

33.

Chiam PTL, Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am Heart J. 2009;157:229–42.CrossRefPubMed

34.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr F-W, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve Prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.CrossRefPubMed

35.

Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde J-C, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg. 2007;134:1150–6.CrossRefPubMed

36.

Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MWA, Schuler G, Mohr FW. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg. 2008;33:983–8.CrossRefPubMed

37.

Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009–16.CrossRefPubMed

Title: Artificial valves “up to date” in Japan
Authors: Shigehiko Tokunaga
Ryuji Tominaga
Publication date: 01-07-2010
Publisher: Springer Japan
Published in: Journal of Artificial Organs / Issue 2/2010
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI: https://doi.org/10.1007/s10047-010-0507-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Artificial valves “up to date” in Japan

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Extracorporeal membrane oxygenation as a “bridge to recovery” in a case of myotomy for myocardial bridge complicated by biventricular dysfunction

Vacuum-assisted closure with Safetac technology for mediastinitis in patients with a ventricular assist device

Basic study of a transcutaneous information transmission system using intra-body communication

Preparation of in-vivo tissue-engineered valved conduit with the sinus of Valsalva (type IV biovalve)

High-dose carvedilol therapy for mechanical circulatory assisted patients

Preliminary studies for the development of a second generation granulocytapheresis (G-CAP) column